280 likes | 457 Views
HOT topics in Medication Management. John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014. JDJ Consulting, LLC Benchmarking 1 st Q. 2014, Purchasing/Formulary Cost. Buying Group Yes or No , Group Name. Ofirmev on Formulary Yes or No.
E N D
HOT topicsinMedication Management John Karwoski, RPh, MBA JDJ Consulting, LLC john@jdjconsulting.net 03.19.2014
JDJ Consulting, LLC Benchmarking 1st Q. 2014,Purchasing/Formulary Cost
Ofirmev on Formulary Yes or No
Drug Cost Most drug cost comes directly off the bottom line
Drivers of Drug CostNew Technology • New pharmaceutical are more costly than the older version – ARE THEY WORTH THE COST? • P and T must review the data to determine the relative effectiveness, relative toxicity, relative cost and relative benefit. • Some are worth it and some are not but you need to analyze
Drivers of Drug Cost New technology Contract compliance Inefficient purchasing Inefficient processing Waste Packaging and unit size Physician preference Adverse events
Drug Cost Drug Cost Components AWP – what is cost? Contract with buying group Contract with wholesaler Wastage Out dates Overcharges Billing Errors Inventory Management
Inefficient PurchasingInjections • Zofran $10.44 vs. Ondansetron $0.76 • Lanoxin $3.06 vs. digoxin inj $1.70 • Zantac $ 3.91 vs. ranitidine $0.95 • Lopresson $14.00 vs. metoprolol $1.43 • Suprane Vendor 1 $193.24 vs. Suprane Vendor 2 $ 173.80 • These are examples of findings from a recent JDJ review of ASC invoices
Drivers of Drug Cost • Wholesaler overcharges – who checks • Outages- who is responsible • Outages – are you reimbursed for them • Reverse distributor
Opportunities • Inventory Cost • Wholesale contract • Buying group contract
Management of Drug Cost • Efficient Management • Formulary management • Buying Group • Wholesaler contract • Utilization of generics day 1 • Utilization of therapeutic interchange • Check invoices • Charge backs • Reduce waste • Inventory management
Drug cost • Who is managing your drug cost?